NM8074

· NovelMed Therapeutics

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for NM8074, covering 2025-03-11 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy [Phase 2]